Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma

Bibliography

• Hirata K, Egawa S, Kimura Y, et al. Current status of surgery for pancreatic cancer. Dig Surg 2007;24(2):137-47
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59(4):225-49
   PubMed Web of Science ®Google Scholar
• Heinemann V, Boeck S, Hinke A, et al. Evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer. BMC Cancer 2008;8:82
   PubMed Web of Science ®Google Scholar
• Sultana A, Tudur Smith C, Cunningham D, et al. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses. Br J Cancer 2008;99(1):6-13
   PubMed Web of Science ®Google Scholar
• Ozaka M, Matsumura Y, Ishii H, et al. Randomized phase II study of gemcitabine and s-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization pc-01 study). Cancer Chemother Pharmacol 2012;69(5):1197-204
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Ohuchida J, Ohtsuka T, et al. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology 2002;2(5):484-90
   PubMed Web of Science ®Google Scholar
• Uehara H, Nakaizumi A, Ishikawa O, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 2008;57(11):1561-5
   PubMed Web of Science ®Google Scholar
• Tanno S, Nakano Y, Koizumi K, et al. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas 2010;39(1):36-40
   PubMed Web of Science ®Google Scholar
• Ingkakul T, Sadakari Y, Ienaga J, et al. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg 2010;251(1):70-5
   PubMed Web of Science ®Google Scholar
• Kanno A, Satoh K, Hirota M, et al. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J Gastroenterol 2010;45(9):952-9
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The c. Elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75(5):843-54
   PubMed Web of Science ®Google Scholar
• He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature 2005;435(7043):828-33
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6(11):857-66
   PubMed Web of Science ®Google Scholar
• He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007;447(7148):1130-4
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435(7043):834-8
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105(30):10513-18
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18(10):997-1006
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Gen 2008;9(2):102-14
   PubMed Web of Science ®Google Scholar
• Ichikawa D, Komatsu S, Konishi H, et al. Circulating microRNA in digestive tract cancers. Gastroenterology 2012;142(5):1074-8
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011;108(12):5003-8
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011;13(4):423-33
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010;101(10):2087-92
   PubMed Web of Science ®Google Scholar
• Hasselmann DO, Rappl G, Tilgen W, et al. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem 2001;47(8):1488-9
   PubMed Web of Science ®Google Scholar
• Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009;19(2):43-51
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9(6):654-9
   PubMed Web of Science ®Google Scholar
• Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008;10(12):1470-6
   PubMed Web of Science ®Google Scholar
• Rechavi O, Erlich Y, Amram H, et al. Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs. Genes Dev 2009;23(16):1971-9
   PubMed Web of Science ®Google Scholar
• Morimura R, Komatsu S, Ichikawa D, et al. Novel diagnostic value of circulating mir-18a in plasma of patients with pancreatic cancer. Br J Cancer 2011;105(11):1733-40
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Komatsu S, Ichikawa D, et al. Clinical impact of circulating mir-221 in plasma of patients with pancreatic cancer. Br J Cancer 2013;108(2):361-9
   PubMed Web of Science ®Google Scholar
• Abue M, Yokoyama M, Shibuya R, et al. Circulating mir-483-3p and mir-21 is highly expressed in plasma of pancreatic cancer. Int J Oncol 2015;46(2):539-47
   PubMed Web of Science ®Google Scholar
• Szafranska AE, Davison TS, John J, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007;26(30):4442-52
   PubMed Web of Science ®Google Scholar
• Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007;297(17):1901-8
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Zhang H, et al. Mirna-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor epb41l3. Mol Cancer Res 2011;9(7):824-33
   PubMed Web of Science ®Google Scholar
• Kurashige J, Watanabe M, Iwatsuki M, et al. Overexpression of microRNA-223 regulates the ubiquitin ligase fbxw7 in oesophageal squamous cell carcinoma. Br J Cancer 2012;106(1):182-8
   PubMed Web of Science ®Google Scholar
• Zardo G, Ciolfi A, Vian L, et al. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood 2012;119(17):4034-46
   PubMed Web of Science ®Google Scholar
• Wei Y, Yang J, Yi L, et al. Mir-223-3p targeting sept6 promotes the biological behavior of prostate cancer. Sci Rep 2014;4:7546
   PubMed Web of Science ®Google Scholar
• Sobin LH, Compton CC. TNM seventh edition: what’s new, what’s changed: Communication from the international union against cancer and the American Joint Committee on cancer. Cancer 2010;116(22):5336-9
   PubMed Web of Science ®Google Scholar
• Tsujiura M, Ichikawa D, Komatsu S, et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010;102(7):1174-9
   PubMed Web of Science ®Google Scholar
• Komatsu S, Ichikawa D, Takeshita H, et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2011;105(1):104-11
   PubMed Web of Science ®Google Scholar
• Konishi H, Ichikawa D, Komatsu S, et al. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer 2012;106(4):740-7
   PubMed Web of Science ®Google Scholar
• Komatsu S, Ichikawa D, Hirajima S, et al. Plasma microRNA profiles: identification of mir-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma. Br J Cancer 2014;111(8):1614-24
   PubMed Web of Science ®Google Scholar
• Komatsu S, Ichikawa D, Takeshita H, et al. Prognostic impact of circulating mir-21 and mir-375 in plasma of patients with esophageal squamous cell carcinoma. Expert Opin Biol Ther 2012;12(Suppl 1):S53-9
   PubMed Web of Science ®Google Scholar
• Hirajima S, Komatsu S, Ichikawa D, et al. Clinical impact of circulating mir-18a in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2013;108(9):1822-9
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta c(t)) method. Methods 2001;25(4):402-8
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29(9):e45
   PubMed Web of Science ®Google Scholar
• Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta paediatrica 2007;96(5):644-7
   PubMed Web of Science ®Google Scholar
• Pritchard CC, Kroh E, Wood B, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 2011;5(3):492-7
   PubMed Web of Science ®Google Scholar
• Benson EA, Skaar TC. Incubation of whole blood at room temperature does not alter the plasma concentrations of microRNA-16 and -223. Drug Metab Dispos 2013;41(10):1778-81
   PubMed Web of Science ®Google Scholar